Cargando…

Fecal Microbiota Transplantation in Patients with HBV Infection or Other Chronic Liver Diseases: Update on Current Knowledge and Future Perspectives

Liver disease and gut dysbiosis are strictly associated, and the pathophysiology of this bidirectional relationship has recently been the subject of several investigations. Growing evidence highlights the link between gut microbiota composition, impairment of the gut-liver axis, and the development...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paratore, Mattia, Santopaolo, Francesco, Cammarota, Giovanni, Pompili, Maurizio, Gasbarrini, Antonio, Ponziani, Francesca Romana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231596/ https://www.ncbi.nlm.nih.gov/pubmed/34204748 http://dx.doi.org/10.3390/jcm10122605

Ejemplares similares

Gut microbiota modulation in patients with non-alcoholic fatty liver disease: Effects of current treatments and future strategies
por: Maestri, Marta, et al.
Publicado: (2023)

Molecular and Clinical Features of Hepatocellular Carcinoma in Patients with HBV-HDV Infection
por: Costante, Federico, et al.
Publicado: (2023)

Non-Invasive Biomarkers for Immunotherapy in Patients with Hepatocellular Carcinoma: Current Knowledge and Future Perspectives
por: Pallozzi, Maria, et al.
Publicado: (2022)

Gut Microbiota and Infectious Complications in Advanced Chronic Liver Disease: Focus on Spontaneous Bacterial Peritonitis
por: Maccauro, Valeria, et al.
Publicado: (2023)

Bariatric Surgery and Liver Disease: General Considerations and Role of the Gut–Liver Axis
por: Cerreto, Maria, et al.
Publicado: (2021)

Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment
por: Stella, Leonardo, et al.
Publicado: (2022)

Gut Microbiota and Neuroinflammation in Acute Liver Failure and Chronic Liver Disease
por: Giuli, Lucia, et al.
Publicado: (2023)

Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows
por: Costante, Federico, et al.
Publicado: (2022)

Correlation Between Liver Function Tests Abnormalities and Interleukin-6 Serum Levels in Patients With SARS-CoV-2 Infection
por: Ponziani, Francesca Romana, et al.
Publicado: (2021)

Risk factors for portal vein thrombosis or venous thromboembolism in a large cohort of hospitalized cirrhotic patients
por: Faccia, Mariella, et al.
Publicado: (2022)

Diagnostic and therapeutic potential of the gut microbiota in patients with early hepatocellular carcinoma
por: Ponziani, Francesca Romana, et al.
Publicado: (2019)

Fecal Microbiota Transplantation in Inflammatory Bowel Disease: Beyond the Excitement
por: Ianiro, Gianluca, et al.
Publicado: (2014)

Future Modulation of Gut Microbiota: From Eubiotics to FMT, Engineered Bacteria, and Phage Therapy
por: Airola, Carlo, et al.
Publicado: (2023)

Improved gut microbiota features after the resolution of SARS‑CoV‑2 infection
por: De Maio, Flavio, et al.
Publicado: (2021)

Low seroprevalence of SARS-CoV-2 antibodies in cirrhotic patients
por: Del Zompo, Fabio, et al.
Publicado: (2021)

Fecal Microbiota Transplantation: Screening and Selection to Choose the Optimal Donor
por: Bibbò, Stefano, et al.
Publicado: (2020)

Type 2 Diabetes Mellitus and Liver Disease: Across the Gut–Liver Axis from Fibrosis to Cancer
por: Manilla, Vittoria, et al.
Publicado: (2023)

Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation
por: Ponziani, Francesca Romana, et al.
Publicado: (2017)

NAFLD or comorbidities, that is the question
por: Ponziani, Francesca Romana, et al.
Publicado: (2020)

The Gut–Vascular Barrier as a New Protagonist in Intestinal and Extraintestinal Diseases
por: Di Tommaso, Natalia, et al.
Publicado: (2023)

Role of Akkermansia in Human Diseases: From Causation to Therapeutic Properties
por: Pellegrino, Antonio, et al.
Publicado: (2023)

Fecal Microbiota Transplantation and Other Gut Microbiota Manipulation Strategies
por: Quaranta, Gianluca, et al.
Publicado: (2022)

Endotoxemia and Gastrointestinal Cancers: Insight into the Mechanisms Underlying a Dangerous Relationship
por: Manilla, Vittoria, et al.
Publicado: (2023)

Low ADAMTS-13/VWF ratio and altered gut–liver axis predict complications of advanced chronic liver disease: a pilot study
por: Ponziani, Francesca Romana, et al.
Publicado: (2022)

Molecular Mechanisms Underlying Vascular Liver Diseases: Focus on Thrombosis
por: Giuli, Lucia, et al.
Publicado: (2023)

SIRT in 2025
por: Ponziani, Francesca Romana, et al.
Publicado: (2022)

Gut Dysbiosis and Fecal Calprotectin Predict Response to Immune Checkpoint Inhibitors in Patients With Hepatocellular Carcinoma
por: Ponziani, Francesca Romana, et al.
Publicado: (2022)

Microvascular Thrombosis and Liver Fibrosis Progression: Mechanisms and Clinical Applications
por: Airola, Carlo, et al.
Publicado: (2023)

Nasopharyngeal Microbiota Profiling of SARS-CoV-2 Infected Patients
por: De Maio, Flavio, et al.
Publicado: (2020)

Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis C
por: Ponziani, Francesca Romana, et al.
Publicado: (2017)

Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study
por: Ianiro, Gianluca, et al.
Publicado: (2020)

The Role of Transabdominal Ultrasound Elastography in Gastrointestinal Non-Liver Diseases: Current Application and Future Prospectives
por: Paratore, Mattia, et al.
Publicado: (2023)

The New Era of Systemic Treatment for Hepatocellular Carcinoma: From the First Line to the Optimal Sequence
por: Cerreto, Maria, et al.
Publicado: (2023)

Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center
por: Ianiro, Gianluca, et al.
Publicado: (2021)

Treatment of hepatocellular carcinoma in patients with portal vein tumor thrombosis: Beyond the known frontiers
por: Cerrito, Lucia, et al.
Publicado: (2019)

Fecal Microbiota Transplantation: An Update on Clinical Practice
por: Kim, Kyeong Ok, et al.
Publicado: (2019)

COVID-19 as a trigger of irritable bowel syndrome: A review of potential mechanisms
por: Settanni, Carlo Romano, et al.
Publicado: (2021)

Subclinical atherosclerosis is linked to small intestinal bacterial overgrowth via vitamin K2-dependent mechanisms
por: Ponziani, Francesca Romana, et al.
Publicado: (2017)

Shear Wave Dispersion in Chronic Liver Disease: From Physical Principles to Clinical Usefulness
por: Garcovich, Matteo, et al.
Publicado: (2023)

“Bacterial Consortium”: A Potential Evolution of Fecal Microbiota Transplantation for the Treatment of Clostridioides difficile Infection
por: Quaranta, Gianluca, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pomtuhbjphm83cgigj9urkgmhn